Janus Henderson Group PLC Acquires 6,057,477 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Janus Henderson Group PLC grew its holdings in Surgery Partners, Inc. (NASDAQ:SGRY) by 110.2% during the 4th quarter, Holdings Channel reports. The firm owned 11,554,845 shares of the company’s stock after purchasing an additional 6,057,477 shares during the period. Janus Henderson Group PLC owned approximately 0.09% of Surgery Partners worth $244,616,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. Franklin Resources Inc. raised its position in shares of Surgery Partners by 19.5% in the 3rd quarter. Franklin Resources Inc. now owns 21,324 shares of the company’s stock valued at $677,000 after acquiring an additional 3,487 shares during the period. JPMorgan Chase & Co. raised its position in shares of Surgery Partners by 3.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 189,436 shares of the company’s stock valued at $6,107,000 after acquiring an additional 5,551 shares during the period. Harbor Capital Advisors Inc. raised its position in shares of Surgery Partners by 25.2% in the 4th quarter. Harbor Capital Advisors Inc. now owns 67,443 shares of the company’s stock valued at $1,428,000 after acquiring an additional 13,588 shares during the period. Inspire Investing LLC raised its position in shares of Surgery Partners by 47.5% in the 4th quarter. Inspire Investing LLC now owns 19,034 shares of the company’s stock valued at $403,000 after acquiring an additional 6,131 shares during the period. Finally, KBC Group NV raised its position in shares of Surgery Partners by 66.1% in the 4th quarter. KBC Group NV now owns 3,962 shares of the company’s stock valued at $84,000 after acquiring an additional 1,577 shares during the period.

Insider Transactions at Surgery Partners

In other news, CFO David T. Doherty sold 6,733 shares of the firm’s stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $24.02, for a total transaction of $161,726.66. Following the completion of the transaction, the chief financial officer now directly owns 150,868 shares of the company’s stock, valued at $3,623,849.36. This trade represents a 4.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Marissa Brittenham sold 3,156 shares of the firm’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $24.09, for a total transaction of $76,028.04. Following the transaction, the insider now directly owns 63,408 shares of the company’s stock, valued at $1,527,498.72. This represents a 4.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.30% of the company’s stock.

Surgery Partners Stock Performance

Shares of SGRY stock opened at $22.20 on Monday. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The company has a market capitalization of $2.85 billion, a P/E ratio of -46.25, a price-to-earnings-growth ratio of 19.21 and a beta of 1.96. The company’s 50 day moving average price is $22.61 and its two-hundred day moving average price is $23.37. Surgery Partners, Inc. has a 52 week low of $19.50 and a 52 week high of $33.97.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Monday, March 3rd. The company reported $0.39 EPS for the quarter, topping the consensus estimate of $0.38 by $0.01. The firm had revenue of $864.40 million for the quarter, compared to the consensus estimate of $828.09 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. On average, analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

SGRY has been the topic of a number of analyst reports. Macquarie cut their price target on shares of Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 11th. Benchmark reiterated a “buy” rating and issued a $35.00 price target on shares of Surgery Partners in a research report on Monday, April 21st. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $35.00 price target on shares of Surgery Partners in a research report on Tuesday, March 25th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $34.75.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.